Technical Analysis for OCS - Oculis Holding AG
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -2.14% | |
Calm After Storm | Range Contraction | -2.14% | |
NR7 | Range Contraction | -2.14% | |
Narrow Range Bar | Range Contraction | -2.14% | |
Down 3 Days in a Row | Weakness | -2.14% | |
Gapped Down | Weakness | -2.14% | |
Calm After Storm | Range Contraction | -2.68% | |
Narrow Range Bar | Range Contraction | -2.68% |
Alert | Time |
---|---|
10 DMA Resistance | about 3 hours ago |
60 Minute Opening Range Breakdown | about 7 hours ago |
2x Volume Pace | about 7 hours ago |
1.5x Volume Pace | about 7 hours ago |
3x Volume Pace | about 7 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Lausanne, Switzerland.
Sector: Financial Services
Industry: Shell Companies
Keywords: Medicine Biopharmaceutical Disease Organ Systems Diabetes Ophthalmology Glaucoma Diabetic Retinopathy Macular Edema Diabetic Macular Edema Blindness Retinopathy Dry Eye Disease Ophthalmic Diseases
Classification
Sector: Financial Services
Industry: Shell Companies
Keywords: Medicine Biopharmaceutical Disease Organ Systems Diabetes Ophthalmology Glaucoma Diabetic Retinopathy Macular Edema Diabetic Macular Edema Blindness Retinopathy Dry Eye Disease Ophthalmic Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 14.495 |
52 Week Low | 9.05 |
Average Volume | 46,001 |
200-Day Moving Average | 11.62 |
50-Day Moving Average | 11.89 |
20-Day Moving Average | 12.27 |
10-Day Moving Average | 12.61 |
Average True Range | 0.39 |
RSI (14) | 53.49 |
ADX | 23.92 |
+DI | 27.81 |
-DI | 21.41 |
Chandelier Exit (Long, 3 ATRs) | 12.12 |
Chandelier Exit (Short, 3 ATRs) | 11.89 |
Upper Bollinger Bands | 13.12 |
Lower Bollinger Band | 11.42 |
Percent B (%b) | 0.56 |
BandWidth | 13.83 |
MACD Line | 0.26 |
MACD Signal Line | 0.23 |
MACD Histogram | 0.0296 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 12.76 | ||||
Resistance 3 (R3) | 12.80 | 12.71 | 12.70 | ||
Resistance 2 (R2) | 12.71 | 12.61 | 12.69 | 12.67 | |
Resistance 1 (R1) | 12.54 | 12.55 | 12.50 | 12.50 | 12.65 |
Pivot Point | 12.45 | 12.45 | 12.43 | 12.43 | 12.45 |
Support 1 (S1) | 12.28 | 12.35 | 12.24 | 12.24 | 12.09 |
Support 2 (S2) | 12.19 | 12.29 | 12.17 | 12.07 | |
Support 3 (S3) | 12.02 | 12.19 | 12.05 | ||
Support 4 (S4) | 11.98 |